Martyn Caplin DM, FRCP

Prof. Martyn Caplin is a Professor of Gastroenterology and neuroendocrine Cancer Biology at the Royal Free Hospital and University College London. He leads The Royal Free Hospital’s “European Neuroendocrine Tumour Society Centre of Excellence”. Furthermore, he leads scientific and clinical research programs into neuroendocrine tumors across University College London. He has been the chief investigator and principal investigator in many key clinical trials. He was a founder member of the European Neuroendocrine Tumor Society (ENETS) in 2004. He was elected Chairman of ENETS 2014-2016 and now serves on its advisory board.

He is a founder and Past-Chairman of the UK & Ireland Neuroendocrine Tumour Society and received a Lifetime Achievement Award from the UK & Ireland Neuroendocrine Tumour Society (UKI NETS) in recognition of his clinical leadership and research in the field of NETs. He was a member of the National Cancer Research Institute (NCRI) Upper-G.I. Cancer Committee and he is a Past-Chairman of the NCRI Neuroendocrine Tumour group. Between 2016 and 2021 he was Chairman of the European Union Reference Network for Rare Cancers Neuroendocrine Tumor Group.

He is a Patron of the NET Patient Foundation. He is a founder member of SPARC a European policy committee promoting the role and accessibility of radioligand therapies in Europe. In the field of gastroenterology, he was the clinical lead for “NHS Evidence” for Gastroenterology and Liver diseases (under the auspices of NICE), chairing annual evidence updates into gastrointestinal and liver disorders. He has published over 250 peer-reviewed papers, written multiple book chapters, and co-authored two books. He regularly lectures both nationally and internationally.